| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
A-Raf proto-oncogene, serine/threonine kinase | 0.619 | 0.654 | 0.96 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2018 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1994 | 2008 | ||||||||
|
abhydrolase domain containing 11 | 0.839 | 0.154 | 3.0E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
abhydrolase domain containing 5 | 0.641 | 0.538 | 6.4E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ABI family member 3 binding protein | 0.686 | 0.385 | 1.0E-08 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2009 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.900 | 10 | 0 | 1993 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
abnormal spindle microtubule assembly | 0.526 | 0.769 | 3.4E-49 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2019 | |||||||||
|
ABRA C-terminal like | 0.931 | 0.077 | 0.24 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
abraxas 2, BRISC complex subunit | 0.760 | 0.308 | 2.0E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
absent in melanoma 2 | 0.521 | 0.769 | 2.2E-09 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
acetyl-CoA acetyltransferase 1 | 0.538 | 0.692 | 9.9E-08 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2020 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 2009 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
achaete-scute family bHLH transcription factor 1 | 0.552 | 0.692 | 0.68 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 2000 | 2019 | ||||||||
|
achaete-scute family bHLH transcription factor 2 | 0.691 | 0.423 | 0.35 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acid phosphatase 2, lysosomal | 0.780 | 0.346 | 6.2E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
acid phosphatase 5, tartrate resistant | 0.561 | 0.731 | 7.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acidic nuclear phosphoprotein 32 family member A | 0.674 | 0.577 | 0.99 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2009 | ||||||||
|
acidic nuclear phosphoprotein 32 family member B | 0.541 | 0.731 | 0.96 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2015 | ||||||||
|
acidic nuclear phosphoprotein 32 family member C | 0.931 | 0.077 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
acidic nuclear phosphoprotein 32 family member E | 0.839 | 0.115 | 0.84 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |